A citation-based method for searching scientific literature

Danielle Campfield Bonadies, Anne Moyer, Ellen T Matloff. Fam Cancer 2011
Times Cited: 40







List of co-cited articles
261 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation.
A Finch, K A Metcalfe, J K Chiang, L Elit, J McLaughlin, C Springate, R Demsky, J Murphy, B Rosen, S A Narod. Gynecol Oncol 2011
129
42

Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer.
Joanna B Madalinska, Judith Hollenstein, Eveline Bleiker, Marc van Beurden, Heiddis B Valdimarsdottir, Leon F Massuger, Katja N Gaarenstroom, Marian J E Mourits, René H M Verheijen, Eleonora B L van Dorst,[...]. J Clin Oncol 2005
169
35

Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomy.
Mark Robson, Martee Hensley, Richard Barakat, Carol Brown, Dennis Chi, Elizabeth Poynor, Kenneth Offit. Gynecol Oncol 2003
99
35

A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer.
Carolyn Y Fang, Carol Cherry, Karthik Devarajan, Tianyu Li, John Malick, Mary B Daly. Gynecol Oncol 2009
65
35

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
872
32

Looking different, feeling different: women's reactions to risk-reducing breast and ovarian surgery.
Nina Hallowell, Brandi Baylock, Louise Heiniger, Phyllis N Butow, Deepa Patel, Bettina Meiser, Christobel Saunders, Melanie A Price. Fam Cancer 2012
46
27

The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.
Joanna B Madalinska, Marc van Beurden, Eveline M A Bleiker, Heiddis B Valdimarsdottir, Judith Hollenstein, Leon F Massuger, Katja N Gaarenstroom, Marian J E Mourits, René H M Verheijen, Eleonora B L van Dorst,[...]. J Clin Oncol 2006
145
25


Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
25


Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
Iris van Oostrom, Hanne Meijers-Heijboer, Litanja N Lodder, Hugo J Duivenvoorden, Arthur R van Gool, Caroline Seynaeve, Conny A van der Meer, Jan G M Klijn, Bert N van Geel, Curt W Burger,[...]. J Clin Oncol 2003
195
22

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
22

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.
Kelly A Metcalfe, Daphna Birenbaum-Carmeli, Jan Lubinski, Jacek Gronwald, Henry Lynch, Pal Moller, Parviz Ghadirian, William D Foulkes, Jan Klijn, Eitan Friedman,[...]. Int J Cancer 2008
250
22


The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function.
R Rosen, C Brown, J Heiman, S Leiblum, C Meston, R Shabsigh, D Ferguson, R D'Agostino. J Sex Marital Ther 2000
20

Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Theresa Wagner, Henry T Lynch, Judy E Garber, Mary B Daly, Claudine Isaacs, Olufunmilayo I Olopade, Susan L Neuhausen, Laura van 't Veer,[...]. J Clin Oncol 2005
270
20

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003
20

Prevalence of sexual dysfunction after risk-reducing salpingo-oophorectomy.
Paige E Tucker, Max K Bulsara, Stuart G Salfinger, Jason Jit-Sun Tan, Helena Green, Paul A Cohen. Gynecol Oncol 2016
25
32


The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation.
Amy Finch, Kelly A Metcalfe, Jaclyn Chiang, Lorraine Elit, John McLaughlin, Caitlin Springate, Mary Jane Esplen, Rochelle Demsky, Joan Murphy, Barry Rosen,[...]. Psychooncology 2013
61
17

Relationship satisfaction predicts sexual activity following risk-reducing salpingo-oophorectomy.
Tierney Lorenz, Bonnie McGregor, Elizabeth Swisher. J Psychosom Obstet Gynaecol 2014
13
53

Sexual activity and functioning after risk-reducing salpingo-oophorectomy: Impact of hormone replacement therapy.
Nora Johansen, Astrid H Liavaag, Tom G Tanbo, Alv A Dahl, Are H Pripp, Trond M Michelsen. Gynecol Oncol 2016
29
24

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
Amy Finch, Mario Beiner, Jan Lubinski, Henry T Lynch, Pal Moller, Barry Rosen, Joan Murphy, Parviz Ghadirian, Eitan Friedman, William D Foulkes,[...]. JAMA 2006
402
15

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.
Noah D Kauff, Susan M Domchek, Tara M Friebel, Mark E Robson, Johanna Lee, Judy E Garber, Claudine Isaacs, D Gareth Evans, Henry Lynch, Rosalind A Eeles,[...]. J Clin Oncol 2008
365
15


Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Noah D Kauff, Jaya M Satagopan, Mark E Robson, Lauren Scheuer, Martee Hensley, Clifford A Hudis, Nathan A Ellis, Jeff Boyd, Patrick I Borgen, Richard R Barakat,[...]. N Engl J Med 2002
876
15

Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent.
D Gareth R Evans, Fiona Lalloo, Linda Ashcroft, Andrew Shenton, Tara Clancy, Andrew D Baildam, Anne Brain, Penelope Hopwood, Anthony Howell. Cancer Epidemiol Biomarkers Prev 2009
102
15

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
15

Risk-reducing bilateral salpingo-oophorectomy and sexual health: a qualitative study.
Lori A Brotto, Nadia Branco, Cara Dunkley, Mary McCullum, Jessica N McAlpine. J Obstet Gynaecol Can 2012
11
54

Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT.
J Challberg, L Ashcroft, F Lalloo, B Eckersley, R Clayton, P Hopwood, P Selby, A Howell, D G Evans. Br J Cancer 2011
49
12

Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause.
W A Rocca, J H Bower, D M Maraganore, J E Ahlskog, B R Grossardt, M de Andrade, L J Melton. Neurology 2007
472
12

Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study.
Yvonne Brandberg, Kerstin Sandelin, Staffan Erikson, Göran Jurell, Annelie Liljegren, Annika Lindblom, Ann Lindén, Anna von Wachenfeldt, Marie Wickman, Brita Arver. J Clin Oncol 2008
146
12



Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective study.
K Tiller, B Meiser, P Butow, M Clifton, B Thewes, M Friedlander, K Tucker. Gynecol Oncol 2002
52
12

Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: uptake and timing.
A-B Skytte, A-M Gerdes, M K Andersen, L Sunde, K Brøndum-Nielsen, M Waldstrøm, S Kølvraa, D Crüger. Clin Genet 2010
74
12

Surveillance of survivors: follow-up after risk-reducing salpingo-oophorectomy in BRCA 1/2 mutation carriers.
Jocelyn S Chapman, C Bethan Powell, Jane McLennan, Beth Crawford, Julie Mak, Nicola Stewart, Lee-May Chen. Gynecol Oncol 2011
33
15

Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.
Andrea Eisen, Jan Lubinski, Jacek Gronwald, Pal Moller, Henry T Lynch, Jan Klijn, Charmaine Kim-Sing, Susan L Neuhausen, Lucy Gilbert, Parviz Ghadirian,[...]. J Natl Cancer Inst 2008
128
12

Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.
J L Shifren, G D Braunstein, J A Simon, P R Casson, J E Buster, G P Redmond, R E Burki, E S Ginsburg, R C Rosen, S R Leiblum,[...]. N Engl J Med 2000
587
12



Women's constructions of the 'right time' to consider decisions about risk-reducing mastectomy and risk-reducing oophorectomy.
A Fuchsia Howard, Joan L Bottorff, Lynda G Balneaves, Charmaine Kim-Sing. BMC Womens Health 2010
21
23

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.
Amy P M Finch, Jan Lubinski, Pål Møller, Christian F Singer, Beth Karlan, Leigha Senter, Barry Rosen, Lovise Maehle, Parviz Ghadirian, Cezary Cybulski,[...]. J Clin Oncol 2014
362
12


Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation.
Elizabeth Hall, Amy Finch, Michelle Jacobson, Barry Rosen, Kelly Metcalfe, Ping Sun, Steven A Narod, Joanne Kotsopoulos. Gynecol Oncol 2019
21
23

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
10

Positive, negative, and disparate--women's differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy.
Andrea Altschuler, Larissa Nekhlyudov, Sharon J Rolnick, Sarah M Greene, Joann G Elmore, Carmen N West, Lisa J Herrinton, Emily L Harris, Suzanne W Fletcher, Karen M Emmons,[...]. Breast J 2008
63
10


Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004
719
10

Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy.
M H Frost, D J Schaid, T A Sellers, J M Slezak, P G Arnold, J E Woods, P M Petty, J L Johnson, D L Sitta, S K McDonnell,[...]. JAMA 2000
211
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.